FILTER

LATEST INTERVIEWS

Mining
Peru

Jorge León Benavides

PRESIDENT, CANADA PERU CHAMBER OF COMMERCE (CCCP)
The Canada Peru Chamber of Commerce continues looking at means of attracting further investments into Peru’s mining industry.
Mining
Chile

Iván Arriagada

CEO, ANTOFAGASTA PLC
Antofagasta explains how the company is leading changes in how copper is mined in the modern age.
Mining
Peru

Víctor Gobitz

PRESIDENT, PERUVIAN INSTITUTE OF MINING ENGINEERS (IIMP)
The Peruvian Institute of Mining Engineers sets forth the challenges for the country’s mining industry in 2021.
Petrochemicals & Chemicals
Singapore

Danny Foong

GENERAL MANAGER, ARKEMA
Arkema continues to expand in Asia from Singapore and set an example with an ambitions approach towards sustainability.
Petrochemicals & Chemicals
Singapore

EngLeong Goh

MANAGING DIRECTOR, BASF (MALAYSIA) SDN BHD AND HEAD OF MALAYSIA-SINGAPORE BUSINESS AREA
BASF in Southeast Asia describes its response to changing conditions.
Mining
Burkina Faso
MACIG

Gordon Stothart

PRESIDENT AND CEO, IAMGOLD CORPORATION
IAMGOLD describes how organic growth will drive the company for the immediate future.
Mining
Canada

Vance White

PRESIDENT & CEO, NOBLE MINERAL EXPLORATION
Noble Mineral Exploration provides an update on its portfolio.
Mining
Mali
MACIG

Nana Bompeh Sangmuah

PRESIDENT AND CEO, ROSCAN GOLD
Roscan Gold describes progress at its Kandiolé project in Mali.
Mining
Canada

Ruben Padilla

PRESIDENT & CEO, SABLE RESOURCES
Sable Resources explains the potential of its portfolio of resources in Latin America.
Mexico
Petrochemicals & Chemicals

Federico Soto

DIRECTOR GENERAL, ÓRGANO SÍNTESIS
Órgano Síntesis is enjoying a period of rapid expansion to catch up with unprecedented demand.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL